[ad_1]
One of the world’s most prestigious consulting firms, McKinsey & Company, advised Purdue Pharma to give drugstore discounts for OxyContin overdoses in 2017, according to documents released last week in a federal court of bankruptcies in New York.
Documents submitted to court last week revealed that McKinsey allegedly gave advice to the Sackler family on ways to boost sales of Oxycontin amid the opioid epidemic, according to a New York Times report.
The documents, filed on behalf of attorneys general in several states, reportedly revealed that at a 2017 meeting, Mckinsey allegedly suggested that Purdue give a discount for each overdose of OxyContin linked to pills sold by pharmaceutical companies such as CVS, according to the Times.
The 2017 presentation reportedly estimated the number of corporate customers, including CVS and Anthem, who could overdose on OxyContin, according to the newspaper.
McKinsey estimated that 2,484 CVS clients would overdose or become dependent on opioids in 2019, and that he would pay a rebate of $ 14,810 “per event,” according to documents obtained by The Times.
CVS and Anthem press officers told The Times the companies had never received a discount from Purdue customers who overdosed on the drug.
McKinsey’s involvement with Purdue Pharma came to light after Massachusetts, one of the states suing Purdue, released documents last year linking the two companies.
The documents reportedly showed the consulting firm was helping Purdue find a way to counter the “emotional” message from worried mothers with overdosed children, according to the Times.
Purdue pleaded guilty to three federal criminal charges this week relating to some of its sales and marketing practices associated with the powerful pain reliever Oxycontin.
[ad_2]
Source link